You are here: Industry Insights > Clinical Trials

News List

COVID-19 poll: Disrupted clinical trials will take six to 12 months to return to normal pharmaceutical-technology
August 06, 2020
The COVID-19 pandemic significantly disrupted ongoing clinical trials in various stages, with more than 1,000 trials by sponsors, collaborators, or contract research organisations having gone off the trial schedules.
Serum Institute of India gets DCGI nod for phase 2 and 3 human trials of Oxford vaccine candidate expresspharma
August 04, 2020
As per the study design, each subject will be administered two doses four weeks apart (first dose on day one and second dose on day 29) following which the safety and immunogenicity will be assessed at predefined intervals.
Number of US COVID-19 clinical trials surpasses China: GlobalData expresspharma
July 28, 2020
Clinical trials in India also growing at a higher rate, and the country is now in fourth place for COVID-19 trials.
Volition Announces Promising Clinical Trials Results for its Novel COVID-19 Triage Test July 14,2020
July 14, 2020
Cameron Reynolds, Chief Executive Officer of Volition commented, "Nu.QTM has shown correlation with more severe COVID-19 cases implying strong prognostic potential, and we are now focused on the completion of larger longitudinal studies that would be need
Inhaled formulation of remdesivir enters clinical trials europeanpharmaceuticalreview
July 14, 2020
Gilead reveals the novel inhaled formulation of remdesivir entered Phase I trials to establish if it could be used to treat mild to moderate COVID-19.
Mount Sinai, Emergent, and ImmunoTek Form Collaboration contractpharma
July 14, 2020
To develop Emergent’s COVID-19 hyperimmune globulin product candidate with U.S. DoD funding.
Approved COVID-19 vaccine could be available in six months; high-risk groups should get priority access: Poll pharmaceutical-technolog
July 13, 2020
The global spread of the COVID-19 pandemic and the resulting economic impact and public health burden has highlighted the urgent need for a vaccine to prevent the disease.
New clinical trial platform launched to accelerate COVID-19 treatments pharmatimes
July 09, 2020
The University of Liverpool, Liverpool School of Tropical Medicine and Southampton Clinical Trials Unit have launched an innovative COVID-19 drug testing platform, AGILE, in the hope of accelerating the development of the most promising therapies.
Immune Regulation Ltd Partners with DynPort Vaccine Company to Advance its Drug Product for COVID-19 into Clinical Trials b3cnewswire
July 08, 2020
Immune Regulation Ltd, a US and UK based clinical stage biotechnology company, today announced that it has entered into a Teaming Agreement with DynPort Vaccine Company LLC (DVC; a GDIT Company) to jointly evaluate the potential of Immune Regulation’s dru
CR UK calls on Scottish gov to 'urgently' restart cancer trials pharmatimes
June 30, 2020
As of this morning – Tuesday June 30 – the current recorded case count for COVID-19 (coronavirus) in the UK has reached 311,965 with 43,575 deaths.

Previous page 1 2 3 4 5 6 7 8 9 10 ... 13 14 Next page